ATP13A2 Gene PARK9 Parkinson Genetic Test
Test Name: ATP13A2 Gene PARK9 Parkinson Genetic Test
Components: Blood or Extracted DNA or One drop Blood on FTA Card
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Neurological Disorders
Doctor: Neurologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for ATP13A2 Gene PARK9 Parkinson NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ATP13A2 Gene PARK9 Parkinson.
Test Details
The ATP13A2 gene, also known as PARK9, is associated with a rare form of Parkinson’s disease called Kufor-Rakeb syndrome. Mutations in this gene can lead to the development of Parkinson’s-like symptoms, including movement difficulties, cognitive decline, and psychiatric symptoms.
NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously, providing a comprehensive assessment of an individual’s genetic makeup. In the context of Parkinson’s disease, NGS genetic testing can identify mutations in the ATP13A2 gene, helping to diagnose Kufor-Rakeb syndrome.
Genetic testing for Parkinson’s disease can be beneficial for several reasons. It can provide a definitive diagnosis, which can help guide treatment decisions and provide important information for family planning. Additionally, genetic testing can also help researchers understand the underlying causes of Parkinson’s disease and potentially develop targeted therapies in the future.
If you suspect you or someone you know may have Kufor-Rakeb syndrome or a genetic form of Parkinson’s disease, it is recommended to consult with a genetic counselor or a healthcare professional who specializes in genetic testing. They can provide guidance on the appropriate testing options and help interpret the results.
| Test Name | ATP13A2 Gene PARK9 Parkinson Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for ATP13A2 Gene PARK9 Parkinson NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with ATP13A2 Gene PARK9 Parkinson |
| Test Details |
The ATP13A2 gene, also known as PARK9, is associated with a rare form of Parkinson’s disease called Kufor-Rakeb syndrome. Mutations in this gene can lead to the development of Parkinson’s-like symptoms, including movement difficulties, cognitive decline, and psychiatric symptoms. NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously, providing a comprehensive assessment of an individual’s genetic makeup. In the context of Parkinson’s disease, NGS genetic testing can identify mutations in the ATP13A2 gene, helping to diagnose Kufor-Rakeb syndrome. Genetic testing for Parkinson’s disease can be beneficial for several reasons. It can provide a definitive diagnosis, which can help guide treatment decisions and provide important information for family planning. Additionally, genetic testing can also help researchers understand the underlying causes of Parkinson’s disease and potentially develop targeted therapies in the future. If you suspect you or someone you know may have Kufor-Rakeb syndrome or a genetic form of Parkinson’s disease, it is recommended to consult with a genetic counselor or a healthcare professional who specializes in genetic testing. They can provide guidance on the appropriate testing options and help interpret the results. |
